Atlas market file · Etf · United States
Sarmaya Thematic ETFLENS
- Last close
- 42.921
- Change
- +1.77%
- 96-bar range
- 38.005 – 46.8
- As of
- 7 Aug 2026
Sarmaya Thematic ETF is an exchange-traded fund listed as LENS on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 81 weekly closes (+69.58% over the window).
Source rail: Yahoo Finance chart API (LENS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for LENS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
LENS public profile
Exchange-traded fund. Sarmaya Thematic ETF is connected to current market context, cited company sources and its retained research file.
Sarmaya Thematic ETF trades as LENS on BATS. Sarmaya Thematic ETF (LENS) has a latest verified close of 42.921, up 1.77%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. LENS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Sarmaya Thematic ETF today
The LENS ETF (Sarmaya Thematic ETF) listed on Nasdaq in 2026 with a mandate to track ‘global thematic opportunities,’ though its actual holdings-as disclosed in SEC filings-resemble a diversified but unremarkable mix of mid-cap equities and other ETFs. The fund charges a 0.55% expense ratio, positioning itself as a premium thematic play while its underlying components suggest a more vanilla construction.
According to its SEC EDGAR prospectus, LENS employs a ‘rules-based’ methodology to select assets aligned with themes like AI, clean energy, and fintech, but retains discretion to adjust the basket ‘in response to market conditions.’ This flexibility hasn’t yet translated into relative strength, though the fund’s marketing materials emphasize narrative over nuance. Trading volume on Nasdaq shows sporadic retail interest, often correlating with social media trends around its stated themes.
FINRA’s Fund Analyzer highlights LENS’s modest $45M in assets under management and a bid-ask spread that occasionally widens during low-liquidity periods. While the fund’s thematic pitch appeals to retail investors seeking simplified exposure, its actual risk-return profile may underwhelm those scrutinizing its holdings. The issuer’s website promises ‘innovation at scale,’ yet the portfolio’s heavy reliance on existing ETFs raises questions about layering fees without adding alpha.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
LENS technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on LENS
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep LENS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
LENS FAQ
What is Sarmaya Thematic ETF (LENS)?Sarmaya Thematic ETF (LENS) has a latest verified close of 42.921, up 1.77%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
Sarmaya Thematic ETF (LENS) has a latest verified close of 42.921, up 1.77%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for LENS?Sarmaya Thematic ETF (LENS) has a latest verified close of 42.921, up 1.77%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources,...
Sarmaya Thematic ETF (LENS) has a latest verified close of 42.921, up 1.77%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. LENS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the LENS page updated?The LENS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The LENS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for LENS?The LENS file starts with Nasdaq Trader and TradingView BATS:LENS. The page separates verified market context from company evidence and shows open evidence gaps instead...
The LENS file starts with Nasdaq Trader and TradingView BATS:LENS. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on LENS?Yes. The workstation can open LENS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open LENS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this LENS page investment advice?No. The LENS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The LENS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
LENS
Etf · evidence first